New 5-ylidene rhodanine derivatives based on the dispacamide A model

Molecular Diversity

Volumn 18, Issue 2, 2014, Pages 375-388

  Guiheneuf, Solene ^a   Paquin, Ludovic ^a   Carreaux, François ^a   Durieu, Emilie ^b   Roisnel, Thierry ^a   Meijer, Laurent ^c   Bazureau, Jean Pierre ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b CNRS   (France)

^c CRCM Centre de Perharidy   (France)

Author keywords

2 Thioxo imidazoline 4 one; 5 Ylidene rhodanine; Kinase; Knoevenagel condensation; Microwave condensation; Rhodanine

Indexed keywords

3 (4 OXO 2 THIOXOTHIAZOLIDIN 3 YL)PROPIONIC ACID; 4 METHOXY N (4 OXO 2 THIOXOTHIAZOLIDIN 3 YL)BENZAMIDE; 4,5 DIBROMO 1H PYRROL 2 CARBOXYLIC ACID[3 (3 AMINO 4 OXO 2 THIOXOTHIAZOLIDIN 5 YLIDENE]PROPYL]AMIDE; 4,5 DIBROMO 1H PYRROL 2 CARBOXYLIC ACID[3 (3 BENZENESULFONYLAMINO 4 OXO 2 THIOXOTHIAZOLIDIN 5 YLIDENE]PROPYL]AMIDE; 4,5 DIBROMO 1H PYRROL 2 CARBOXYLIC ACID[3 (4 OXO 2 THIOXOTHIAZOLIDIN 5 YLIDENE)PROPYL]AMIDE; 4,5 DICHLORO 1H PYRROL 2 CARBOXYLIC ACID[3 (4 OXO 2 THIOXOTHIAZOLIDIN 5 YLIDENE)PROPYL]AMIDE; EXOCYCLIC DOUBLE BOND; IMIDAZOLINE; N (4 OXO 2 THIOXOTHIAZOLIDIN 3 YL) 2 PHENYLACETAMIDE; N (4 OXO 2 THIOXOTHIAZOLIDIN 3 YL) 3 PHENYLPROPIONAMIDE; N (4 OXO 2 THIOXOTHIAZOLIDIN 3 YL)BENZAMIDE; N (4 OXO 2 THIOXOTHIAZOLIDIN 3 YL)BENZENESULFONAMIDE; PIPERIDINE; PROTEIN KINASE; RHODANINE; UNCLASSIFIED DRUG; [5 [3 [(4,5 DIBROMO 1H PYRROL 2 CARBONYL)AMINO]PROPYLIDENE] 4 OXO 2 THIOXOTHIAZOLIDIN 3 YL]ACETIC ACID; [5 [3 [(4,5 DIBROMO 1H PYRROL 2 CARBONYL)AMINO]PROPYLIDENE] 4 OXO 2 THIOXOTHIAZOLIDIN 3 YL]PROPIONIC ACID; PROTEIN KINASE INHIBITOR; PYRROLE DERIVATIVE;

ARTICLE; CHEMICAL ANALYSIS; DRUG STRUCTURE; DRUG SYNTHESIS; GEOMETRY; HYDROGEN BOND; KNOEVENAGEL CONDENSATION; MICROWAVE IRRADIATION; MICROWAVE RADIATION; PRIORITY JOURNAL; ROOM TEMPERATURE; THIN LAYER CHROMATOGRAPHY; X RAY DIFFRACTION; ANALOGS AND DERIVATIVES; CHEMISTRY; SYNTHESIS;

CHEMISTRY TECHNIQUES, SYNTHETIC; PROTEIN KINASE INHIBITORS; PYRROLES; RHODANINE;

EID: 84898781526     PISSN: 13811991     EISSN: 1573501X     Source Type: Journal    
DOI: 10.1007/s11030-014-9509-7     Document Type: Article

References (53)

1. Hotta N, Akanuma Y, Kawamori R, Matsuoka K, Oka Y, Shichiri M, Toyota T, Nakashima M, Yoshimura I, Sakamoto N, Shigeta Y (2006) Long-term clinical effects of Epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy. Diabetes Care 29:1538-1544. doi: 10.2337/dc05-2370
2. El-Kabbani Ruiz F, Darmanim C, Chung RP-T (2004) Aldose reductase structures: implications for mechanism and inhibition. Cell Mol Life Sci 61:750-752. doi: 10.1007/s00018-003-3403-2
3. Heng S, Tieu W, Hautmann S, Kuan K, Pedersen DS, Pietsch M, Güutschow M, Abell AD (2011) New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffolds. Bioorg Med Chem 19:7453-7463. doi: 10.1016/j.bmc.2011.10.042
4. Degterev A, Lugovskoy A, Cardone M, Mulley B, Wagner G, Mitchison T, Yuan J (2001) Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-x L. Nat Cell Biol 3:173-182. doi: 10.1038/35055085
5. Wang L, Kong F, Kokoski CL, Andrews DW, Xing C (2008) Development of dimeric modulators for anti-apoptotic Bcl-2 proteins. Bioorg Med Chem Lett 18:236-240. doi: 10.1016/j.bmcl.2007.10.088
6. Summerer D, Rudinger N-Z, Ilka Detmer I, Marx A (2005) Enhanced fidelity in mismatch extension by DNA polymerase through directed combinatorial enzyme design. Angew Chem Int Ed 44:4712-4715. doi: 10.1002/anie.200500047
7. Strittmatter T, Bareth B, Immel TA, Huhn T, Mayer TU, Marx A (2011) Small molecule inhibitors of human DNA polymerase λ. Chem Biol 6:314-319. doi: 10.1021/cb100382m
8. Bulic B, Pickhardt M, Schmidt B, Mandelkow EM, Waldmann H, Mandelkow E (2009) Development of tau aggregation inhibitors for Alzheimer's disease. Angew Chem Int Ed 48:1740-1752. doi: 10.1002/anie.200802621
9. Bulic B, Pickhardt M, Mandelkow EM, Mandelkow E (2010) Tau protein and tau aggregation inhibitors. Neuropharmacology 59:276-289. doi: 10.1016/j.neuropharm.2010.01.016
10. Mishra R, Bulic B, Sellin D, Jha S, Waldmann H, Winter R (2008) Small-molecule inhibitors of islet amyloid polypeptide fibril formation. Angew Chem Int Ed 47:4679-4682. doi: 10.1002/anie.200705372
11. Whitesitt C-A, Simon R-L, Reel J-K, Sigmund S-K, Phillips M-L, Shadle J-K, Heinz L-J, Koppel G-A, Hunden D-C, Lifer S-L, Berry D, Ray J, Little S-P, Liu X, Marshall W-S, Panetta J-A (1996) Synthesis and structure-activity relationships of benzophenones as inhibitors of cathepsin D. Bioorg Med Chem Lett 6:2157-2162. doi: 10.1016/0960-0894X(96)00393-9
12. Kumar G, Parasuraman P, Sharma SK, Banerjee T, Karmodiya K, Surolia N, Surolia A (2007) Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase. J Med Chem 50:2665-2675. doi: 10.1021/jm061257w
13. Soltero-Higgin M, Carlson E-E, Phillips J-H, Kiessling L-L (2004) Identification of inhibitors for UDP-galactopyranose mutase. J Am Chem Soc 126:10532-10533. doi: 10.1021/ja048017v
14. Powers J-P, Piper D-E, Li Y, Mayorga V, Anzola J, Chen J-M, Jaen J-C, Lee G, Liu J, Peterson M-G, Tonn G-R, Ye Q, Walker NPC, Wang Z (2006) SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase. J Med Chem 49:1034-1046. doi: 10.1021/jm050859x
15. Rajamaki S, Innitzer A, Falciani C, Tintori C, Christ F, Witvrouw M, Debyser Z, Massa S, Botta M (2009) Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors. Bioorg Med Chem Lett 19:3615-3618. doi: 10.1016/j.bmcl.2009.04.132
16. Dayam R, Sanchez T, Neamati N (2005) β -Diketo acid pharmacophore. 1. Discovery of structurally diverse inhibitors of HIV-1 integrase inhibitors. J Med Chem 48:111-120. doi: 10.1021/jm0496077
17. Kodimuthali A, Jabaris SSL, Pal M (2008) Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease. J Med Chem 51:5471-5885. doi: 10.1021/jm800582j
18. Sherida L, Johnson SL, Chen L-H, Harbach R, Sabet M, Savinov A, Cotton NJH, Strongin A, Guiney D, Pellecchia M (2008) Rhodanine derivatives as selective protease inhibitors against bacterial toxins. Chem Biol Drug Des 71:131-139. doi: 10.1111/j.1747-0285.2007.00617.x
19. Bazureau J-P, Carreaux F, Renault S, Meijer L, Lozach O, Patent WO 2009/05032 A2, 23 April 2009. Demande PCT/FR 2008/001152, 01 October 2008
20. Debdab M, Renault S, Lozach O, Meijer L, Paquin L, Carreaux F, Bazureau J-P (2010) Synthesis and preliminary biological evaluation of new derivatives of the marine alkaloid leucettamine B as kinase inhibitors. Eur J Med Chem 45:805-810. doi: 10.1016/j.ejmech.2009.10.009
21. Debdab M, Carreaux F, Renault S, Soundararajan M, Federov O, Lozach O, Babault L, Baratte B, Ogawa Y, Hagiwara M, Einsenreich A, Rauch U, Knapp S, Meijer L, Bazureau J-P (2011) Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing. J Med Chem 54:4172-4186. doi: 10.1021/jm200274d
22. Tahtouh T, Federov O, Soundararajan M, Burgy G, Durieu E, Lozach O, Cochet C, Schmid R-S, Lo D-C, Delhommel F, Oberholzer A-E, Pearl L-H, Carreaux F, Bazureau J-P, Knapp S, Meijer L (2012) Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B. J Med Chem 55:9312-9330. doi: 10.1021/jm301034u
23. Burgy G, Tahtouh T, Durieu E, Josselin-Foll B, Limanton E, Meijer L, Carreaux F, Bazureau J-P (2013) Chemical synthesis and biological validation of immobilized protein kinase inhibitory leucettines. Eur J Med Chem 62:728-737. doi: 10.1016/j.ejmech.2013.01.035
24. Cafieri F, Fattorusso E, Mangoni A, Taglialatela-Scafati O (1996) Dispacamides, anti-Histamine alkaloids from Caribbean Agelas Sponges. Tetrahedron Lett 37:3587-3590. doi: 10.1016/0040-4039(96)00629-6
25. Guiheneuf S, Paquin L, Carreaux F, Durieu E, Meijer L, Bazureau J-P (2012) An efficient approach to dispacamide A and its derivatives. Org Biomol Chem 10:978-987. doi: 10.1039/c1ob06161e
26. Guiheneuf S, Paquin L, Carreaux F, Durieu E, Meijer L, Bazureau J-P (unpublished results)
27. de la Hoz A, Loupy A (eds) (2012) Microwave in organic synthesis. Wiley-VCH, Weinheim. ISBN 978-3-527-33116-1
28. Bazureau J-P, Draye M (eds) (2011) Ultrasound and microwave: recent advances in organic chemistry. Research Signpost, Kerala. ISBN 978-81-7895-532-2
29. Radi M, Botta M, Falchi F, Maga G, Baldanti F, Paolucci S, Patent WO 2011/039735, 07 April 2011. Demande PCT/IT 2010/054475, 04 October 2010
30. Kamila S, Biehl ER (2012) Microwave-assisted synthesis of novel bis(2-thioxothiazolidin-4-one) derivatives as potential GSK-3 inhibitors. Tetrahedron Lett 53:3998-4003. doi: 10.1016/j.tetlet.2012.05.088
31. Nitsche C, Klein CD (2012) Aqueous microwave-assisted one-pot synthesis of N-substituted rhodanines. Tetrahedron Lett 53:5197-5201. doi: 10.1016/j.tetlet.2012.07.002
32. Heng S, Tieu W, Hautmann S, Kuan K, Pedersen DS, Pietsch M, Gütschow M, Abell AD (2011) New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffolds. Bioorg Med Chem 19:7453-7463. doi: 10.1016/j.bmc.2011.10.042
33. Safonov I-G, Heerding D-A, Keenan R-M, Price A-T, Erickson-Muller C-L, Hopson C-B, Levin J-L, Lord K-A, Tapley P-M (2006) New benzimidazoles as thrombopoietin receptor agonists. Bioorg Med Chem Lett 16:1212-1216. doi: 10.1016/j.bmcl.2005.11.096
34. Tomašić T, Zidar N, Rupnik V, Kovač A, Blanot D, Gobec S, Kikelj D, Mašič LP (2009) Synthesis and biological evaluation of new glutamic acid-based inhibitors of MurD ligase. Bioorg Med Chem Lett 19:153-157. doi: 10.1016/j.bmcl.2008.10.129
35. Tomašić T, Zidar N, Mueller-Premru M, Kikelj D, Mašič LP (2010) Synthesis and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-4,6-pyrimidinediones. Eur J Med Chem 45:1667-1672. doi: 10.1016/j.ejmech.2009.12.030
36. Zidar N, Tomasic T, Sink R, Rupnik V, Kovac A, Turk S, Patin D, Blanot D, Contreras Martel C, Dessen A, Mueller-Premru M, Zega A, Gobec S, Peterlin Masic L, Kikelj D (2010) Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase. J Med Chem 53:6584-6594. doi: 10.1021/jm100285g
37. Zidar N, Tomašić T, Šink R, Kovač A, Patin D, Blanot D, Contreras-Martel C, Dessen A, Mueller-Premru M, Zega A, Gobec S, Mašič LP, Kikelj D (2011) New 5-benzylidenethiazolidin-4-one inhibitors of bacterial MurD ligase: design, synthesis, crystal structures, and biological evaluation. Eur J Med Chem 46:5512-5523. doi: 10.1016/j.ejmech.2011. 09.017
38. Chen H, Fan Y-H, Natarajan A, Guo Y, Iyasere J, Harbinski F, Luis L, Christ W, Aktas H, Halperin J (2004) Synthesis and biological evaluation of thiazolidine-2,4-dione and 2,4-thione derivatives as inhibitors of translation initiation. Bioorg Med Chem Lett 14:5401-5405. doi: 10.1016/j.bmcl.2004.08.017
39. Whitesitt CA, Simon RL, Reel Jon K, Sigmund SK, Phillips ML, Shadle JK, Heinz LJ, Koppel GA, Hundel DC, Lifer SL, Berry D, Ray J, Little SP, Liu X, Marshall W (1996) Synthesis and structure-activity relationships of benzophenones as inhibitors of cathepsin D. Bioorg Med Chem Lett 6:2157-2162. doi: 10.1016/0960-894X(96)00393-9
40. Lee B, Jung ME, Wolf MC, Zhang T, Patent WO 2010/044924, 22 April 2010. Demande PCT/US 2009/047854, 18 June 2009
41. Opletalova V, Dolezel J, Kralova K, Pesko M, Kunes J, Jampilek J (2011) Synthesis and characterization of (Z) -5-arylmethylidenerhodanines with photosynthesis-inhibiting properties. Molecules 16:5207-5227. doi: 10.3390/molecules16065207
42. Alizadeh A, Khodaei MM, Eshghi A (2010) A solvent-free protocol for the green synthesis of arylalkylidene rhodanines in a task-specific ionic liquid. Can J Chem 88:514-518. doi: 10.1139/V10-011
43. Gong K, He ZW, Xu Y, Fang D, Liu Z-L (2008) Green synthesis of 5-benzylidene rhodanine derivatives catalyzed by 1-butyl-3-methyl imidazolium hydroxide in water. Monatsh Chem 139:913-915. doi: 10.1007/s00706-008-0871-y
44. Ben-Alloum A, Bakkas S, Bougrin K, Soufiaoui M (1998) Synthèse de nouvelles spiro-rhodanine-pyrazolines par addition dipolaire-1,3 de la diphenylnitrilimine sur quelques 5-arylidènerhodanines en "milieu sec" et sous irradiation micro-onde. New J Chem 22:809-812. doi: 10.1039/A803447H
45. Sing WT, Lee CL, Yeo SL, Lim SP, Sim MM (2001) Arylalkylidene rhodanine with bulky and hydrophobic functional group as selective HCV NS3 protease inhibitor. Bioorg Med Chem Lett 11:91-94. doi: 10.1016/S0960-894X(00)00610-7
46. Altomare A, Burla MC, Camalli M, Cascarano G, Giacovazzo C, Guagliardi A, Moliterni AGG, Polidori G, Spagna R (1999) SIR97: a new tool for crystal structure determination and refinement. J Appl Cryst 32:115-119. doi: 10.1107/S0021889898007717
47. Sheldrick GM (2008) A short history of SHELX. Acta Cryst A64:112-122. doi: 10.1107/S0108767307043930
48. Farrugia LJ (1999) WinGX suite for small-molecule single-crystal crystallography. J Appl Cryst 32:837-838. doi: 10.1107/S0021889899006020
49. van der Sluis P, Spek AL (1990) BYPASS: an effective method for the refinement of crystal structures containing disordered solvent regions. Acta Cryst A46:194-201. doi: 10.1107/S0108767389011189
50. Spek AL (2003) Single-crystal structure validation with the program PLATON. J Appl Cryst 36:7-13. doi: 10.107/S0021889802022112
51. Leclerc S, Garnier M, Hoessel R, Marko D, Bibb JA, Snyder GL, Greengard P, Biernat J, Mandelkow E-M, Eisenbrand G, Meijer L (2001) Indirubins inhibit glycogen synthase kinase-3 β and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease: a property common to most cyclin-dependant kinase inhibitors? J Biol Chem 276:251-260. doi: 10.1074/jbc.M002466200
52. Primot A, Baratte B, Gompel M, Borgne A, Liabeuf S, Romette JL, Costantini F, Meijer L (2000) Purification of GSK-3 by affinity chromatography on immobilized axin. Protein Expr Purif 20:394-404. doi: 10.1006/prep.2000.1321
53. Reinhardt J, Ferandin Y, Meijer L (2007) Purification of CK1 by affinity chromatography on immobilised axin. Protein Expr Purif 54:101-109. doi: 10.1016/j.pep.2007.02.020